Compassionate and optimum use of new tuberculosis drugs

Lancet Infect Dis. 2015 Oct;15(10):1131. doi: 10.1016/S1473-3099(15)00294-7. Epub 2015 Sep 20.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antitubercular Agents / adverse effects
  • Antitubercular Agents / therapeutic use*
  • Diarylquinolines / adverse effects
  • Diarylquinolines / therapeutic use*
  • Drug Therapy, Combination / methods
  • Extensively Drug-Resistant Tuberculosis / drug therapy*
  • Extensively Drug-Resistant Tuberculosis / surgery*
  • Health Services Accessibility*
  • Humans
  • Male
  • Nitroimidazoles / adverse effects
  • Nitroimidazoles / therapeutic use*
  • Oxazoles / adverse effects
  • Oxazoles / therapeutic use*
  • Pneumonectomy

Substances

  • Antitubercular Agents
  • Diarylquinolines
  • Nitroimidazoles
  • OPC-67683
  • Oxazoles
  • bedaquiline